Alan Scott Enterprises Ltd
Incorporated in 1994, Alan Scott Industries manufacture health and hygiene products for use in hospitals and homes
- Market Cap ₹ 181 Cr.
- Current Price ₹ 317
- High / Low ₹ 415 / 122
- Stock P/E
- Book Value ₹ 19.7
- Dividend Yield 0.00 %
- ROCE -14.1 %
- ROE -45.8 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 16.1 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -88.7% over last 3 years.
- Earnings include an other income of Rs.1.16 Cr.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 0.02 | 1.24 | 5.22 | 11.42 | 28.69 | 34.35 | |
| 0.11 | 1.90 | 5.65 | 11.47 | 26.75 | 33.63 | |
| Operating Profit | -0.09 | -0.66 | -0.43 | -0.05 | 1.94 | 0.72 |
| OPM % | -450.00% | -53.23% | -8.24% | -0.44% | 6.76% | 2.10% |
| 0.09 | 0.67 | 0.06 | 0.35 | 2.25 | 1.16 | |
| Interest | 0.00 | 0.02 | 0.61 | 1.38 | 2.20 | 2.29 |
| Depreciation | 0.00 | 0.05 | 1.08 | 2.41 | 3.80 | 4.06 |
| Profit before tax | 0.00 | -0.06 | -2.06 | -3.49 | -1.81 | -4.47 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | -2.68% | |
| 0.00 | -0.07 | -2.06 | -3.50 | -1.82 | -4.30 | |
| EPS in Rs | 0.00 | -0.11 | -3.50 | -6.48 | -3.37 | -5.21 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 344% |
| 3 Years: | 87% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -32% |
| TTM: | 18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 50% |
| 5 Years: | 86% |
| 3 Years: | 114% |
| 1 Year: | 172% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -79% |
| 3 Years: | -89% |
| Last Year: | -46% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1.19 | 1.83 | 1.83 | 3.62 | 3.63 | 5.72 |
| Reserves | 0.35 | 1.25 | -0.64 | -0.26 | -1.86 | 5.53 |
| 0.05 | 0.17 | 3.00 | 8.62 | 7.38 | 9.65 | |
| 0.00 | 2.32 | 6.20 | 15.87 | 18.10 | 14.96 | |
| Total Liabilities | 1.59 | 5.57 | 10.39 | 27.85 | 27.25 | 35.86 |
| 0.00 | 2.60 | 6.01 | 15.03 | 15.82 | 15.59 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.52 |
| Investments | 0.30 | 0.21 | 0.21 | 0.89 | 1.36 | 2.09 |
| 1.29 | 2.76 | 4.17 | 11.93 | 10.07 | 14.66 | |
| Total Assets | 1.59 | 5.57 | 10.39 | 27.85 | 27.25 | 35.86 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 0.18 | -1.58 | -1.57 | -3.11 | -1.68 | -6.16 | |
| -0.21 | -0.95 | -3.48 | -3.05 | 0.10 | -5.64 | |
| 1.29 | 1.73 | 4.72 | 8.53 | -0.15 | 12.63 | |
| Net Cash Flow | 1.26 | -0.80 | -0.33 | 2.37 | -1.74 | 0.84 |
| Free Cash Flow | 0.18 | -2.15 | -6.05 | -5.48 | -2.47 | -11.92 |
| CFO/OP | -200% | 239% | 365% | 6,240% | -87% | -856% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 2.94 | 0.70 | 13.10 | 7.89 | 6.48 |
| Inventory Days | 124.03 | 227.11 | 211.75 | 88.66 | 119.15 | |
| Days Payable | 88.59 | 107.76 | 126.84 | 15.87 | 18.84 | |
| Cash Conversion Cycle | 0.00 | 38.38 | 120.05 | 98.01 | 80.68 | 106.79 |
| Working Capital Days | -730.00 | 73.59 | -46.15 | -70.63 | 26.33 | 53.13 |
| ROCE % | -27.63% | -35.79% | -26.39% | -14.21% | -14.14% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Operating Subsidiaries companies |
|
||||||||||
| Number of Employees (Group) employees |
|||||||||||
| Number of Retail Stores (Miniso + XTEP) stores |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Jul - Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith a copy of the certificate received from MUFG Intime India Private …
-
Intimation Of Appointment Of Independent Director Pursuant To Regulations 30 Of The SEBI (LODR) Regulations, 2015.
4 Jul - Mr. KP Pradeep appointed Additional Independent Director from July 4, 2026, subject to AGM approval.
-
Closure of Trading Window
29 Jun - Trading window closed from July 1, 2026 until 48 hours after Q1 FY27 results.
-
Announcement under Regulation 30 (LODR)-Change in Management
24 Jun - Board approved draft rights issue offer and reappointed Sureshkumar Jain as MD for five years from June 24, 2026.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, June 24, 2026
24 Jun - Board approved rights issue draft offer letter and reappointed Managing Director Sureshkumar Jain until June 23, 2031.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2012
from bse
-
Financial Year 2006
from bse
-
Financial Year 2005
from bse
Product Profile:
a) 5 petals AIR purifier+[1]
This uses 8 different technologies instead of 5 certified technologies to provide protection from aerosol spread of 99.9% of Virus, Bacteria, fungus and Yeasts
b) 5 Petals O2 Concentrator[2]
It's a supplement of oxygen with a capacity
of 8-25 LPM and a High Purity Oxygen 90-95%
Clientele:[3]
Larsen & Tubro, Som Capital, Rubix,
Thought Bridge HR, Verstech, Sunicon, Sanjivani Parentrals3